Join an exciting new study for OCD

There hasn't been any new medication for OCD since 1997. Biohaven is studying an investigational medication that modulates glutamate, and we want you to know more.


Why participate?

medical bag icon

A new investigational treatment option for OCD

money icon

May receive study-related evaluations and medical care throughout trial

lab icon

Be part of exciting progress in OCD treatment

wave divider

The process to participate

Step 1

Enter your information in the form below.

Step 2

Choose the date and time that works best for us to give you a call.

Step 3

We’ll call you at your scheduled time to discuss your eligibility, options & next steps.

Please fill out the form and schedule a time for us to contact you about this clinical trial.

Do you think you may have OCD or symptoms of OCD?

I am between 18 & 65 years old

Are you taking one of the following?

  • - Fluoxetine (Prozac)
  • - Sertraline (Zoloft)
  • - Clomipramine (Anafranil)
  • - Paroxetine (Paxil)
  • - Venlafaxine (Effexor XR)
  • - Citalopram (Celexa)
  • - Escitalopram (Lexapro)
  • - Desvenlafaxine (Pristiq)
*This information will not be shared with anyone except NOCD and the nearest participating research site.

By having this box checked, you agree to receive marketing messages from NOCD via email or text message. You can unsubscribe at any time.

orange dots divider

About Biohaven

Biohaven Pharmaceuticals in New Haven, Connecticut, is the sponsor of the study. Biohaven researches a range of neurological disorders, and obsessive-compulsive disorder is an important focus of their work.

About NOCD

NOCD is a digital behavioral health company focused on identifying and treating OCD. NOCD is partnering with Biohaven to develop the first new medication for OCD since 1997.

NOCD logo

NOCD Inc, All Rights Reserved